Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical ...

STOCKHOLM, SE / ACCESS Newswire / April 7, 2025 / AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing ...

Parkinson's disease is a progressive neurodegenerative disease hallmarked by motor symptoms and disrupted cognitive functions as well as mental health. The disorder is caused by the loss of nerve ...

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...

Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient care through improved data and AI, presented NeuLogiq® ...

University at Albany associate professor Janet Paluh goes over a poster that outlines ... (development) or nerve (development),” she said. It has all of the different cells in the human heart.

The ASX has been down 1.5% at 7,739 points this morning. There’s been carnage on the ASX and the Energy sector has been ...

Austin City Limits Celebrates 50 Years honors the fifty year-legacy of the longest-running music television series in history with live performances by diverse artists, vintage archival clips, ...

These research results were presented in poster form at the 2025 Annual Meeting ... The human tongue has numerous taste receptor cells, which are sensitive to the different flavors, and taste ...

Scientists have re-created a pain pathway in the brain by growing four key clusters of human nerve cells in a dish. This ...